VIRX   $0.4803  -4.18% Market Closed

Viracta Therapeutics Inc
Total Cash 30.00M
totalCashPerShare 0.761
EBITDA -49.04M
Total Debt 18.82M
quickRatio 1.047
currentRatio 1.084
Total Revenue
debtToEquity 704.568
Revenue/Share
ROA -0.57197
ROE -2.0866702
grossProfits
freeCashflow -26.06M
operatingCashflow -38.24M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.92M
forwardPE -0.36688524
floatShares 24.78M
sharesOutstanding 39.42M
sharesShort 1.33M
sharesShortPriorMonth 1.26M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.49%
Short Ratio help_outline 4.87%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -0.071
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -45.34M
trailingEps -1.16%
forwardEps -0.61%
enterpriseToEbitda -0.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.24 3Q 2024
institutionsCount 47
lastUpdated Oct. 16, 2024, 11:53 p.m.